We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 8,612 results
  1. IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models

    Clinically approved head and neck squamous cell carcinoma (HNSCC) immunotherapies manipulate the immune checkpoint blockade (ICB) axis but have had...

    Justin Yu, Jacob Gadwa, ... Sana D. Karam in Cancer Immunology, Immunotherapy
    Article Open access 30 March 2024
  2. Eosinophils promote CD8+ T cell memory generation to potentiate anti-bacterial immunity

    Memory CD8 + T cell generation is crucial for pathogen elimination and effective vaccination against infection. The cellular and molecular circuitry...

    Jun Zhou, Jiaqi Liu, ... Xuetao Cao in Signal Transduction and Targeted Therapy
    Article Open access 28 February 2024
  3. Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity

    CD8 + T cell immune responses are regulated by multi-layer networks, while the post-translational regulation remains largely unknown. Transmembrane...

    Lina Sun, Anjun Jiao, ... Baojun Zhang in Signal Transduction and Targeted Therapy
    Article Open access 26 June 2024
  4. Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy

    T cell differentiation is a highly regulated, multi-step process necessary for the progressive establishment of effector functions, immunological...

    Yannick Bulliard, Borje S. Andersson, ... Apostolia M. Tsimberidou in Journal of Hematology & Oncology
    Article Open access 25 October 2023
  5. Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score

    Adoptively transferred T cell receptor-engineered T cells are a promising cancer treatment strategy, and the identification of tumour-specific TCRs...

    Chaoting Zhang, Shance Li, ... Zheming Lu in Cancer Immunology, Immunotherapy
    Article Open access 10 May 2024
  6. Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection

    The immunoprotective components control COVID-19 disease severity, as well as long-term adaptive immunity maintenance and subsequent reinfection risk...

    Gang Yang, **peng Cao, ... Zhongfang Wang in Signal Transduction and Targeted Therapy
    Article Open access 29 May 2024
  7. A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma

    Strategies to improve T cell therapy efficacy in solid tumors such as hepatocellular carcinoma (HCC) are urgently needed. The common cytokine...

    Wei Zhu, Zhiming Zhang, ... **lin Hou in Signal Transduction and Targeted Therapy
    Article Open access 20 April 2024
  8. CD8-positive T-cell lymphoproliferative disorder of the uterus: a new subtype of indolent extranodal T-cell neoplasm?

    A 51-year-old female with menorrhagia was found to have a cervical polyp. Polypectomy and endometrial curettage showed an atypical lymphoid...

    Reham Ahmed, Andrew L. Feldman in Journal of Hematopathology
    Article 08 July 2024
  9. Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype

    Bone marrow mesenchymal stromal cells (MSCs) have been described as potent regulators of T-cell function, though whether they could impede the...

    Russell Towers, Lidia Trombello, ... Martin Bornhäuser in Cancer Immunology, Immunotherapy
    Article Open access 17 January 2024
  10. Spatiotemporal commonality of the TCR repertoire in a T-cell memory murine model and in metastatic human colorectal cancer

    Immune checkpoint inhibitors (ICIs) have shown superior clinical responses and significantly prolong overall survival (OS) for many types of cancer....

    Mizuki Haraguchi, Kazuma Kiyotani, ... Ryohei Katayama in Cancer Immunology, Immunotherapy
    Article 04 June 2023
  11. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial

    Background

    Relapse remains a challenge after transplantation in pediatric patients with hematological malignancies. Myeloablative regimens used for...

    Swati Naik, Ying Li, ... Brandon M. Triplett in Journal of Hematology & Oncology
    Article Open access 27 June 2024
  12. C3aR costimulation enhances the antitumor efficacy of CAR-T cell therapy through Th17 expansion and memory T cell induction

    Although chimeric antigen receptor (CAR)-modified adoptive T cell therapy is a promising immunotherapy for hematological malignancies, the efficacy...

    Peilong Lai, **aomei Chen, ... Duanqing Pei in Journal of Hematology & Oncology
    Article Open access 21 May 2022
  13. Central and effector memory T cells in peripheral blood of patients with interstitial pneumonia: preliminary clues from a COVID-19 study

    Background

    SARS-CoV-2 pre-existing T-cell immune reactivity can be present in some people. A general perturbation of the main peripheral lymphocyte...

    Makhabbat Bekbossynova, Lyudmila Akhmaltdinova, ... Dimitri Poddighe in Respiratory Research
    Article Open access 10 October 2022
  14. Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors

    T-cell dysregulation in chronic lymphocytic leukemia (CLL) associates with low response rates to autologous T cell-based therapies. How CLL affects...

    Anne W. J. Martens, Inga Kavazović, ... Arnon P. Kater in Leukemia
    Article 19 January 2023
  15. GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration

    Purpose

    The variable responses to immunotherapy observed in gastric cancer (GC) patients can be attributed to the intricate nature of the tumor...

    Wen**g Zhao, Ziwei Liang, ... Jiannan Yao in Cancer Immunology, Immunotherapy
    Article Open access 15 May 2024
  16. Altered immunity to microbiota, B cell activation and depleted γδ/resident memory T cells in colorectal cancer

    The role of microbiota:immune system dysregulation in the etiology of colorectal cancer (CRC) is poorly understood. CRC develops in gut epithelium,...

    Alistair Noble, Edward T. Pring, ... Stella C. Knight in Cancer Immunology, Immunotherapy
    Article Open access 22 March 2022
  17. Dynamic single-cell map** unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response

    Epstein‒Barr virus (EBV)-associated gastric cancer (GC) manifests an intriguing immunotherapy response. However, the cellular basis for EBV-imprinted...

    Miao-Zhen Qiu, Chaoye Wang, ... Rui-Hua Xu in Signal Transduction and Targeted Therapy
    Article Open access 21 September 2023
  18. An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies

    T-cell malignancies are associated with frequent relapse and high morbidity, which is partly due to the lack of effective or targeted treatment...

    **gyu **ang, Jessica M. Devenport, ... John F. DiPersio in Leukemia
    Article Open access 05 October 2023
  19. Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients

    We conducted a cross-sectional study to evaluate cellular and humoral immunogenicity against severe acute respiratory syndrome coronavirus 2...

    Takaaki Konuma, Megumi Hamatani-Asakura, ... Yasuhito Nannya in International Journal of Hematology
    Article Open access 06 June 2024
  20. Fueling CARs: metabolic strategies to enhance CAR T-cell therapy

    CAR T cells are widely applied for relapsed hematological cancer patients. With six approved cell therapies, for Multiple Myeloma and other B-cell...

    Arne Van der Vreken, Karin Vanderkerken, ... Eline Menu in Experimental Hematology & Oncology
    Article Open access 10 July 2024
Did you find what you were looking for? Share feedback.